Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Blankenstein, Thomas Prof. Dr. (18) Clauß, Julian (1) Daniel, Peter Prof. Dr. (1) Höpken, Uta Elisabeth PD Dr. (1) Ivics, Zoltan Dr. (1) Izsvak, Zsuzsanna Dr. (1) Kammertöns, Thomas Dr. (3) Kieback, Elisa Dr. (3) Kopp, Joachim Dr. (1) Na, Il-Kang Dr. (1) Pezzutto, Antonio Prof. Dr. (1) Rehm, Armin Dr. (1) Schlag, Peter M. Prof. Dr. (1) Uckert, Wolfgang Prof. Dr. (7) (-) Bunse, Mario Dr. (2) (-) Leisegang, Matthias Prof. Dr. rer. nat. (3) (-) Willimsky, Gerald Dr. (6) Bioinformatik der Genregulation (1) Experimentelle Ultrahochfeld-MR (7) Genetik metabolischer und reproduktiver Störungen (6) Genom-Editierung & Krankheitsmodelle (2) Genomics (3) Immunregulation und Krebs (5) Magnetic Resonance (7) Mobile DNA (2) (-) Molekulare Immunologie und Gentherapie (10) Proteom Dynamik (1) Proteomforschung und molekulare Mechanismen bei neurodegenerativen Erkrankungen (1) RNA Biologie und Posttranscriptionale Regulation (1) Transgenics (2) Translationale Onkologie solider Tumore (1) Zelluläre Neurowissenschaften (4) 1997 (1) 1998 (1) 2000 (3) 2002 (1) 2005 (4) 2006 (1) 2007 (2) (-) 2008 (2) 2010 (5) (-) 2011 (2) 2013 (5) 2015 (2) (-) 2016 (2) 2017 (2) (-) 2018 (4) 2019 (2) 2020 (1) 2021 (1) 2022 (3) 2023 (2) 10 Ergebnisse: Active Filter: Bunse, Mario Dr.Leisegang, Matthias Prof. Dr. rer. nat.Willimsky, Gerald Dr.Molekulare Immunologie und Gentherapie 2008201120162018 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 07. Juli 2008 / J Exp Med Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness G. Willimsky M. Czeh C. Loddenkemper J. Gellermann K. Schmidt P. Wust H. Stein T. Blankenstein 01. Oktober 2008 / Int J Cancer SV40 large T antigen-transformed human primary normal and cancerous mammary epithelial cells are phenotypically similar but can be distinguished in 3D culture with selection medium L.P. Li G. Willimsky S. Seitz Y. Xu Y. Li L.E. Schwarz P.M. Schlag T. Blankenstein 01. April 2011 / Gene Ther Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study J. Westermann A. Floercken G. Willimsky A. van Lessen J. Kopp A. Takvorian K. Joehrens A. Lukowsky C. Schoenemann B. Sawitzki H. Pohla R. Frank B. Doerken D.J. Schendel T. Blankenstein A. Pezzutto 30. August 2018 / Blood Oncogene-specific T cells fail to eradicate lymphoma-initiating B cells in mice D. Hoser C. Schön C. Loddenkemper P. Lohneis A.A. Kühl T. Sommermann T. Blankenstein G. Willimsky 01. Juni 2018 / Cancer Res ERAP1-dependent antigen cross-presentation determines efficacy of adoptive T cell therapy in mice K. Schmidt C. Keller A.A. Kühl A. Textor U. Seifert T. Blankenstein G. Willimsky P.M. Kloetzel 01. Mai 2018 / Hum Gene Ther Efficient non-viral T cell engineering by Sleeping Beauty minicircles diminishing DNA toxicity and miRNAs silencing the endogenous TCR J. Clauss M. Obenaus C. Miskey Z. Ivics Z. Izsvák W. Uckert M. Bunse 01. August 2018 / Clin Cancer Res Targeting Merkel cell carcinoma by engineered T cells specific to T-antigens of Merkel cell polyomavirus I. Gavvovidis M. Leisegang G. Willimsky N.J. Miller P. Nghiem T. Blankenstein 28. Juli 2011 / Blood The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed J. Popovic L.P. Li P.M. Kloetzel M. Leisegang W. Uckert T. Blankenstein 01. März 2016 / J Clin Invest Targeting human melanoma neoantigens by T cell receptor gene therapy M. Leisegang T. Kammertoens W. Uckert T. Blankenstein 17. Mai 2016 / Immunity Thymus-derived regulatory T cells are positively selected on natural self-antigen through cognate interactions of high functional avidity E. Kieback E. Hilgenberg U. Stervbo V. Lampropoulou P. Shen M. Bunse Y. Jaimes P. Boudinot A. Radbruch U. Klemm A.A. Kühl R. Liblau N. Hoevelmeyer S.M. Anderton W. Uckert S. Fillatreau
07. Juli 2008 / J Exp Med Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness G. Willimsky M. Czeh C. Loddenkemper J. Gellermann K. Schmidt P. Wust H. Stein T. Blankenstein
01. Oktober 2008 / Int J Cancer SV40 large T antigen-transformed human primary normal and cancerous mammary epithelial cells are phenotypically similar but can be distinguished in 3D culture with selection medium L.P. Li G. Willimsky S. Seitz Y. Xu Y. Li L.E. Schwarz P.M. Schlag T. Blankenstein
01. April 2011 / Gene Ther Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study J. Westermann A. Floercken G. Willimsky A. van Lessen J. Kopp A. Takvorian K. Joehrens A. Lukowsky C. Schoenemann B. Sawitzki H. Pohla R. Frank B. Doerken D.J. Schendel T. Blankenstein A. Pezzutto
30. August 2018 / Blood Oncogene-specific T cells fail to eradicate lymphoma-initiating B cells in mice D. Hoser C. Schön C. Loddenkemper P. Lohneis A.A. Kühl T. Sommermann T. Blankenstein G. Willimsky
01. Juni 2018 / Cancer Res ERAP1-dependent antigen cross-presentation determines efficacy of adoptive T cell therapy in mice K. Schmidt C. Keller A.A. Kühl A. Textor U. Seifert T. Blankenstein G. Willimsky P.M. Kloetzel
01. Mai 2018 / Hum Gene Ther Efficient non-viral T cell engineering by Sleeping Beauty minicircles diminishing DNA toxicity and miRNAs silencing the endogenous TCR J. Clauss M. Obenaus C. Miskey Z. Ivics Z. Izsvák W. Uckert M. Bunse
01. August 2018 / Clin Cancer Res Targeting Merkel cell carcinoma by engineered T cells specific to T-antigens of Merkel cell polyomavirus I. Gavvovidis M. Leisegang G. Willimsky N.J. Miller P. Nghiem T. Blankenstein
28. Juli 2011 / Blood The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed J. Popovic L.P. Li P.M. Kloetzel M. Leisegang W. Uckert T. Blankenstein
01. März 2016 / J Clin Invest Targeting human melanoma neoantigens by T cell receptor gene therapy M. Leisegang T. Kammertoens W. Uckert T. Blankenstein
17. Mai 2016 / Immunity Thymus-derived regulatory T cells are positively selected on natural self-antigen through cognate interactions of high functional avidity E. Kieback E. Hilgenberg U. Stervbo V. Lampropoulou P. Shen M. Bunse Y. Jaimes P. Boudinot A. Radbruch U. Klemm A.A. Kühl R. Liblau N. Hoevelmeyer S.M. Anderton W. Uckert S. Fillatreau